CS Paper Radar

KMGen: A Skill-based Approach for Synthetic Individual Patient Data Generation

Jalen Jiang, Chufan Gao, Ethan Rasmussen, Stephen Z. Xie, Jimeng Sun

cs.LG ·submitted 2026-08-23 21:43 UTC · v1
top venuebenchmarkcode/data

Abstract

Individual patient data (IPD) from clinical trials is the substrate for survival modeling, meta-analysis, and safety research, yet IPD is rarely released. Prior work has addressed only half of this gap: reconstructing Kaplan-Meier (KM) curves from published plots -- typically requiring manual digitization or human-in-the-loop correction -- while offering no mechanism for generating the adverse-event (AE) streams that constitute the other half of a patient record. We introduce KMGen, the first end-to-end framework that (i) fully automates KM curve extraction at accuracy competitive with human-guided tools, and (ii) generates synthetic per-patient AE trajectories from public trial registry records. The extraction stage is a fully automated agentic pipeline -- an agent generates code to extract each step in the KM curve -- achieving a mean Integrated Absolute Error (IAE) of 0.0151 on a 32-plot benchmark spanning clean, edge-case, and adversarial conditions. The IPD generation stage decouples patient archetype extraction from statistical sampling: an LLM distills the trial record into arm-specific statistics, adverse events, patient demographics, and risk multipliers. A mechanistic sampler generates patient events via clinical archetypes, bootstrap rank-correlation coupling to the empirical KM curve (preserving the marginal survival distribution exactly), and cycle-based AE scheduling with an induction/maintenance split. Across three held-out oncology trials spanning an order of magnitude in cohort size and 30 independent regenerations per trial, KMGen achieves mean integrated KM absolute difference $Δ_{\text{KM}}\,{\leq}\,0.051$, sex/ECOG JSD ${\leq}\,0.013$ on 5 of 6 demographic slots, and recovers ${\geq}\,71\%$ of the top-15 AEs by exact MedDRA term under a single fixed parameter set. The pipeline is released as open source at https://github.com/chufangao/kmgen.

Journal ref
Proceedings of Machine Learning Research 340 (2026) 1-60

Closest papers

Nearest neighbours by meaning across the whole index.

StochIKM: Automated High-Fidelity Reconstruction of Individual Patient Data from Published Kaplan-Meier Curves

cs.AI stat.AP ·2026-10-21 ·Liangze Ke, Daniel Zelterman, Wei Wei, Guannan Gong
similarity 0.66
Abstract

Individual patient data are the gold standard for secondary analysis of time-to-event evidence, but they are rarely released, and reconstruction from a published Kaplan-Meier figure could help. Existing methods all claim high fidelity, each judged by whichever agreements it happens to achieve, and each returns a single dataset although the map from figure to data is not bijective. We define fidelity explicitly: a dataset is admissible when it reproduces the risk table exactly, follows the digitized curve to within the image resolution, and respects the printed median, interval and event count. We propose StochIKM, a stochastic algorithm that digitizes the figure with a vision-capable language model and uses the high-fidelity definition as constraints, returning an admissible set of individual patient datasets. A solution is guaranteed to exist whenever the figure has been read correctly, so a failure indicts either the published figure or its digitization. In simulation and in 79 arms from published oncology trials, StochIKM reproduces the published risk tables and medians more closely than LLM-improved IPDfromKM, a high-impact alternative.

0.20

Ascent: An Agentic System over the Model Context Protocol for Real-World Clinical Data Analysis

cs.AI cs.IR ·2026-09-21 ·Angelo Ziletti, Leonardo D'Ambrosi, Melanie Tuchardt, Tim Kondziella
dataset similarity 0.62
Abstract

Answering epidemiological questions from real-world clinical data requires medical coding, schema-aware SQL, and validation of implicit choices about populations, denominators, and time. We present Ascent, an agentic system that exposes medical coding, question answering, and cohort analysis through a shared Model Context Protocol tool surface for standardized and native schemas. We introduce EpiTrap, a dataset testing whether systems avoid recognized pharmacoepidemiological errors, and compare a fixed pipeline with agents across models and orchestrators. With capable models, agents improve accuracy over the fixed pipeline by an average of 27 and 20 percentage points on native and standardized schemas, respectively. These gains require more tool calls and longer runtimes. Experience from real projects highlights the system's value for feasibility assessment, diagnostic iteration, and expert-guided analysis.

0.06

Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation

cs.AI cs.CL ·2026-08-31 ·Bahar İlgen, Yiannos Tolias, Denise Kühnert, Paraskevi Papadopoulou, Magnus Westerlund +3 more
similarity 0.62
Abstract · Review article

Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring.

0.12

TIAgent: From Natural Language to Grounded Agentic Workflows for Computational Pathology

cs.AI q-bio.QMcs.CLcs.MA ·2026-09-30 ·Aakash Madhav Rao, Mark Eastwood, Danielle Belgrave, Fayyaz Minhas
benchmark similarity 0.62
Abstract

Computational pathology (CPath) analyses increasingly depend on multi-step computational workflows that require substantial programming expertise, limiting their accessibility to pathologists and other domain experts without extensive coding experience. Although large language models (LLMs) provide a promising natural-language interface for constructing such analyses, hallucinated operations and incorrect workflow specifications limit their reliability in scientific settings. We introduce Tissue Image Analysis Agent (TIAgent), an automated CPath workflow generation framework that, given a natural-language prompt specifying a complex analytical task together with an input dataset, automatically constructs a verifiable computational graph employing existing CPath operations. The resulting graph can be inspected and executed, enabling natural-language construction of complex CPath workflows for applications including automated biomarker discovery and tissue analysis. We demonstrate end-to-end workflow generation and execution and systematically benchmark 14 backbone LLMs across 90 unit tasks spanning 18 CPath operation types. The ability of each LLM to generate a complete and correct unit workflow is quantified using Unit Workflow Success (UWS). Performance varied substantially across backbone models, with Kimi-K2.7-Code achieving the highest UWS of 0.967 (95% CI: 0.907-0.989). Analysis of node and parameter correctness further revealed that selecting the appropriate computational operation and correctly configuring it represent distinct challenges for LLM-based workflow generation. TIAgent provides a foundation for making complex CPath workflow construction more accessible while enabling systematic evaluation of LLM-driven scientific workflow generation.

0.20

ProCARE: Real-World Study Automation via Profile-Grounded Evidence Contracts

cs.AI ·2026-10-12 ·Zhaoyu Fan, Bowen Han, Jincheng Ou, Yanwei Ren, Zehua He +6 more
top venuebenchmarkcode/data similarity 0.62
Abstract · 42 pages, 5 figures, including appendix. Accepted by NeurIPS'26. Code and benchmark: https://github.com/ZyFanTJ/ProCARE

Real-world studies (RWS) analyze routinely collected healthcare data, such as electronic health records and insurance claims, to estimate treatment effects, monitor safety, and identify risk factors outside randomized trials. Automating RWS with large language model agents is appealing but brittle: valid analyses depend on dataset-specific clinical semantics, including index dates, follow-up windows, patient/event-level units, and outcome boundaries that are often implicit in observational data. This leads to schema mismatches, temporal errors, inconsistent analytical granularity, and unsupported clinical claims. We present ProCARE, a profile-grounded framework that reformulates RWS automation as constrained compilation. ProCARE converts heterogeneous data profiles into Evidence Contracts specifying available variables, temporal attributes, distributions, and evidentiary limits, and compiles study objectives into RWS-IR, a strongly typed intermediate representation for variables, time relations, analysis units, and statistical tasks. Deterministic validation and localized repair then check and revise generated workflows across schema mapping, cohort construction, variable derivation, analysis, and interpretation. On 36 EHR-based benchmark tasks, ProCARE outperforms strong LLM-agent baselines in code executability, semantic consistency, and conclusion traceability, with automated violation diagnoses showing moderate-to-substantial agreement with blinded expert review.

0.73

CoMedBench: A Multi-Source Benchmark of Synthetic Medical Data Fidelity and Downstream Utility

cs.LG ·2026-08-13 ·Akanta Das, Farhad Al-Amin Dipto, Mrinmoy Sarkar Anto, David Rehkopf, Ayin Vala +1 more
benchmark similarity 0.61
Abstract

Access to clinical data is essential for developing reliable healthcare machine learning systems, but direct use of electronic health records is constrained by privacy regulation, institutional review, data-use agreements, and the risk of re-identification. Synthetic data promises a practical alternative: it can preserve useful statistical and clinical structure while reducing exposure of sensitive patient records. Prior studies often evaluate a single generator, one dataset, or a narrow downstream task, making it difficult to know when synthetic data can support model development and when it fails to preserve task-critical signal. We introduce CoMedBench, a reproducible benchmark that evaluates a family of generators under a common clinical-validity framework and one shared training and evaluation engine, spanning static tabular and temporal downstream tasks on established critical-care datasets. In total the benchmark spans 37 dataset-task pairs across two modalities consists of 20 static tabular and 17 temporal ICU time-series-drawn from seven public data sources: three intensive-care databases (MIMIC-III, MIMIC-IV, and eICU) together with the UCI Machine Learning Repository, the CDC BRFSS diabetes cohort (2015), NHANES (1999-2014), and the pycox survival datasets (GBSG and METABRIC). The benchmark evaluates both statistical fidelity and task utility by comparing models trained and tested across real and synthetic data. In these settings, synthetic training data preserves most of the downstream signal: on tabular tasks the reference generator CoMed-CTGAN retains a mean AUROC utility (the synthetic-to-real performance ratio) of 90.6%, rising to 97.3% for the strongest generator, CoMed-TVAE. Temporal ICU tasks are harder and more generator-sensitive: CoMed-CTGAN retains 81.6% (AUROC) and only 64.0% under the imbalance-sensitive AUPRC, whereas CoMed-TVAE still retains ~95% (AUROC).

0.04

From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction

cs.AI ·2026-08-29 ·Daniel Kang, Michelle Hu, Soorya Ram Shimgekar, Shayan Vassef, Yufan Wang +10 more
similarity 0.60
Abstract

Clinically relevant oncology information is distributed across heterogeneous, longitudinal documentation, creating substantial abstraction burden and requiring accurate attribution across specimens, tumors, biomarkers, and time points, while manual cancer-registry abstraction can require 27.2 minutes per case, highlighting the need for scalable methods that preserve clinical context while converting documentation into structured data. We evaluate an oncology information-extraction workflow in which OncoLens supplies multi-source, oncology-aware document selection, aggregation, and normalization from integrated EHRs, while the NimbleMind Multi-Agent System (nMAS) is a configurable oncology information-extraction workflow that extracts clinically relevant structured fields from fragmented oncology documentation. The extraction task uses a clinician-informed schema of 328 attributes spanning report metadata, diagnosis, staging, and cancer-type-specific information. nMAS separates clinician-defined field specifications from model execution and combines complexity-aware extraction, report-level consolidation, and source-grounded validation. The retrospective evaluation included 230 de-identified oncology documents from 40 patients and 418 clinician-reviewed document-field pairs containing 1,126 non-empty reference values. Evaluation focused on fields identified by clinicians as present in the source documents rather than exhaustively annotating all 328 schema fields. nMAS achieved a rank-weighted value-level precision of 82.6%, recall of 87.5%, and F1 of 85.0%, compared with an F1 of 66.4% for an independently implemented UMA-style MiniMax M2.5 comparator. These findings support the feasibility of using a configurable, source-grounded extraction workflow to convert fragmented oncology documentation into reusable structured data.

0.27

CohortFlow: A Steerable Clinical Cohort Curation Agent with Localized Semantic Correction

cs.AI ·2026-10-26 ·Neil Chen, Adrian Serapio, Hanxue Gu, Evan Lee, Kang Wang +1 more
similarity 0.60
Abstract

Language model agents for clinical cohort curation should accommodate evolving eligibility criteria without repeatedly processing unchanged requirements. We introduce CohortFlow, a steerable agent that represents natural language corrections as localized updates to a structured cohort specification and reconciles them with a persistent execution graph. Explicitly recorded semantic dependencies enable affected computations to be selectively invalidated while preserving valid prior results. On 100 scenarios derived from clinical-trial eligibility criteria, comprising 126 correction turns, localized steering achieves 77.0% requirement micro-F1 versus 76.4% for full regeneration using the same 8B model, a small numerical advantage that is not statistically significant ($p=0.493$). It reduces mean correction latency by 64.8% after completion and 44.3% during execution, with 38.1% fewer model calls. In a separate proof-of-concept evaluation over MIMIC, all 13 cohort states execute successfully, while correction trajectories demonstrate selective preservation of unaffected computations and recomputation of changed or dependent nodes. Together, these results show that localized semantic steering can substantially reduce correction latency and model calls while maintaining strong requirement-level accuracy.

0.25